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Summary 
Superantigens are defined by their ability to stimulate a large fraction of T cells via interaction 
with the T cell receptor (TCR) V/3 domain. Endogenous superantigens, classically termed minor 
lymphocyte-stimulating (Mls) antigens, were recently identified as products of open reading flames 
(ORF) in integrated proviral copies of mouse mammary tumor virus (MMTV). We have described 
an infectious MMTV homologue of the classical endogenous superantigen Mls-1  ~ (Mtv-7). The 
ORF molecules of both the endogenous Mtv-7 and the infectious MMTV(SW) interact with 
T cells expressing the TCR VB6, 7, 8.1, and 9 domains. Furthermore, the COOH termini of 
their ORF molecules, thought to confer TCR specificity,  are very similar. Since successful  transport 
of MMTV from the site of infection in the gut to the mammary gland depends on a functional 
immune system, we were interested in determining the early events after and requirements for 
MMTV infection.  We show that MMTV(SW) infection induces a massive response of V~6 + 
CD4 + T cells, which interact with the viral ORE Concomitantly, we observed a B cell response 
and differentiation that depends on both the presence and stimulation of the superantigen-reactive 
T cells. Furthermore, we show that B cells are the main target of the initial MMTV infection 
as judged by the presence of the reverse-transcribed viral genome and ORF transcripts.  Thus, 
we suggest that MMTV infection of B cells leads to ORF-mediated B-T cell interaction,  which 
maintains  and possibly amplifies viral infection. 
M 
inor lymphocyte-stimulating (Mls) antigens are encoded 
by an open reading frame (ORF) z in the 3' LTR of 
endogenous mouse mammary tumor virus (MMTV) (1-3). 
They stimulate a large proportion of T cells due to the fact 
that T cell reactivity to Mls antigens is determined by the 
usage of the V segment of the TCR B chain (4, 5). The clas- 
sical (and  strongest)  Mls  determinant, Mls-1  ',  which in- 
teracts with T cells expressing VB6, 7, 8.1, and 9 elements 
(4-7), is encoded by the ORF of the Mtv-7 proviral locus 
(8). We have recently found an exogenous (infectious)  MMTV, 
MMTV(SW),  with  properties  of Mls-1  '  (9). The  ORF 
molecules of  Mtv-7 and MMTV(SW) display an almost iden- 
tical amino acid sequence, particularly in COOH termini im- 
plied to confer TCR VB specificity. In fact, both endoge- 
nous Mtv-7 and infectious MMTV(SW) interact with the same 
TCR VB elements. In an MMTV-infected host, ORF-reactive 
T cells are deleted from both the thymic and peripheral T 
1 Abbreviations used in this  paper: MMTV, mouse mammary tumor virus; 
ORF, open  reading  frame. 
cell pool, although at a considerably slower rate than after 
expression of the endogenous Mtv-7 (Mls-l') locus. Further- 
more, injection of adult mice with MMTV(SW) leads to ex- 
pansion  of V~6 + CD4 + T  cells similar to  that observed 
after injection of Mls-l'-expressing  B cells (9). A functional 
immune system seems to be a prerequisite for successful  trans- 
port of MMTV to the mammary gland after neonatal infec- 
tion through the gut mucosa. Thus, thymectomy, absence 
of T cells (in nude mice), or deletion of the ORF-reactive 
T  cells prevent  virus  transmission  to  the next generation 
(lO-12). 
While very much attention has been focused on the fate 
ofT cells interacting with Mls, the effects of T-B cell interac- 
tion on the Mls-presenting  B cell have received less atten- 
tion. Generally, it was found that Mls-reactive T cell clones 
provide polyclonal B cell help in vitro (13-15), whereas in 
vivo terminal differentiation  of a minor fraction of the in- 
jected Mls-1  ￿9 B  cells was  found  (16, 17). Since B  cells 
efficiently present ORF molecules from endogenous Mtv's, 
which are then recognized by ORF-specific T  cells, it has 
been speculated that the ORF from infectious MMTVs, like 
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virus integration and replication (18). To test this hypothesis 
we injected adult mice with MMTV(SW), and followed the 
local immune response. MMTV(SW) induces a massive re- 
sponse of the ORF-reactive VB6 + CD4 + T  cells. Concom- 
itant B cell accumulation and differentiation depends on the 
presence of the OR.F-reactive V~6 + CD4 + T  cells.  This re- 
sponse coincides with the presence of reverse-transcribed viral 
genome and ORF mRNA in B cells. Since B cells are known 
to present ORF molecules from endogenous Mtv's ei~ciently 
to T cells, it might be this OR.F-induced B-T interaction that 
maintains and possibly amplifies MMTV infection of B cells. 
Materials and Methods 
Mice.  BALB/c and BALB/c nu/nu mice were purchased from 
HO Harlan OLAC Ltd. (Bicester, UK). Mls-1 ~ (Mtv-7) congenic 
BALB/c (BALB.D2) mice were bred from breeding pairs originally 
obtained from H. Festenstein  (London Hospital Medical College) 
(19). MMTV(SW)-infected BALB/c mice were maintained from 
mice originally purchased from IFFA CREDO (L'Arbresle, France) 
(9).  In all experiments female mice 6-10 wk of age were used. 
Antibodies.  The following mAbs were used in this study: 14.2 
(rat IgM anti-V~14) (20); 44.22.1  (rat IgG anti-V/%) (21); GK1.5 
(anti-CD4)  (22);  F23.1  (mouse IgG2a anti-VB8.1-3)  (23);  Lyt2 
(53.6.7) (anti-CD8) (24); 3.168.8.1 (rat IgM anti-CD8) (25); poly- 
clonal rabbit F(ab)2 anti-mouse Ig. 
Reconstitution of Athymic BALB/c nu/nu Mice.  BALB/c nu/nu 
mice  were  reconstituted  with  either  VB6 +  CD4 +  or  VB14 + 
CD4 + T cells as described (26). Briefly, BALB/c lymph node cells 
were enriched in these T cell subsets by elimination of CD8 + T 
cells through complement lysis using the mAb 3.168.8.1 (anti-CD8). 
B cells and V~8 § T cells were removed by incubation with F23.1 
(anti-V~8.1-3)  followed by goat anti-mouse Ig coupled to mag- 
netic beads (Dynabeads;  Dynal A.S., Oslo, Norway) and elimina- 
tion on a magnet. The cells were then stained directly by fluoresce- 
inated mAb 44.22 (anti-VB6) and biotinylated mAb 14.2 (anti-VB14) 
followed by streptavidin-PE.  VB6 + and V~14 + cells were subse- 
quently sorted using a FACStar Plus |  (Becton Dickinson & Co., 
Mountain View, CA). Sorted cell populations, which were >97% 
pure V~6 + CD4*  or V~14 § CD4 + T  cells, were washed and 
counted. 10  s cells were injected intravenously per BALB/c nu/nu 
mouse. Reconstitution of recipient animals was ascertained  4 wk 
later by analysis of the percentage of the transferred cells among 
total blood lymphocytes. Mice were tail bled and leukocytes were 
recovered from heparinized blood samples by centrifugation through 
a Ficoll  (Pharmacia,  Uppsala,  Sweden)  cushion. 
Milk Collection, Virus Purification, and Virus Titration.  Milk was 
aspirated  from  MMTV(SW)-infected  or  noninfected,  lactating 
BALB/c females after injection of 0.5  IU syntocinon/oxytocine 
(Sandoz, Basel, Switzerland), pooled, and stored at - 70~  A pool 
of milk was diluted 1:2 with PBS and centrifuged at 600 g for 10 
min to skim. The skimmed milk serum was then diluted five times 
with PBS, 0.1 M EDTA, pH 7.4, centrifuged at 15,000 g for 1 h, 
and the virus pellet was resuspended in PBS. Remaining casein ag- 
gregates  were removed by a quick spin at 600 g. The virus titers 
in these preparations were determined using a sandwich ELISA 
specific for MMTV gp52 as described before (9). Purified MMTV 
was diluted at 109 particles/25/~1 and stored in aliquots at -70~ 
Control milk not containing MMTV particles  was  treated and 
diluted accordingly. 
Injections and Sampling.  Purified MMTV  (109 particles)  or a 
virus-free control milk preparation were injected into the hind 
footpads of recipient mice. After the appropriate time the popliteal, 
paraaortic, and inguinal lymph nodes from the injected and nonin- 
jected footpads were isolated and pooled. 
Flow Microfluorometry.  Lymph node cells  (106) were stained 
with anti-TCR VB-specific monodonal hybridoma supernatants 
followed by fluoresceinated anti-rat or anti-mouse IgM or IgG an- 
tisera.  B  ceils  were  detected  using  a  polyclonal  rabbit  F(ab)~ 
anti-mouse Ig directly labeled with fluorescein.  PE-coupled anti- 
CD4 (GK1.5) (Becton Dickinson & Co.) was used in the second 
dimension. Biotinylated anti-CD8 (Lyt2) plus streptavidin-PE Texas 
red  (Tandem;  Southern  Biotechnology  Associates,  Inc.,  Bir- 
mingham,  AL) was used in the third dimension. 
Leukocytes were recovered from heparinized blood samples by 
centrifugation through a Ficoll (Pharmacia)  cushion. These cells 
were stained in one step with a mixture of FITC-labeled anti-TCR 
VB antibody and PE-coupled anti-CD4. For DNA analysis 3  x 
106 cells were stained with FITC-conjugated antibodies  as above, 
washed in PBS, and fixed in 70% ethanol overnight as described 
in (27). Cells were centrifuged at 3,000 rpm for 5 min and stained 
at room temperature in 1 ml PBS containing 1 mg/ml glucose, 
100 Kuntz U/ml KNase A, and 50 #g/ml propidium iodide. The 
cells were analyzed using  the Doublet  Discrimination  Module 
(Becton Dickinson & Co.). Analysis was performed on a FACScan  | 
cell analyzer using Lysys II for data evaluation (Becton Dickinson 
& Co.). 
Ig Estimation.  Levels  of IgM and IgG subclasses in culture su- 
pernatants were determined separately for each subclass by ELISA 
as described (28). Values were expressed  (in/~g/ml) by reference 
to a standard curve obtained with a mouse Ig reference serum (64- 
901; Miles  Scientific, Naperville, IL). Detection limit of the in- 
dividual tests was 10 ng/ml. Total Ig levels correspond to the addi- 
tion of the values for IgM and each of the IgG subclasses. 
Polymerase Chain Reaction.  DNA was isolated from total lymph 
node  cells  or  FACS|  B  and  T  cells  by  digestion  in 
Tris/EDTA/SDS, pH 8.0, plus proteinase K (100 #g/ml) at 52~ 
overnight. DNA was purified and resuspended at a DNA equiva- 
lent of 106 cells per 50 ~1, 20% was used per PCR reaction, cor- 
responding to "~1/~g of genomic DNA. Cellular KNA was iso- 
lated from total lymph node cells or FACS|  B and T cells 
after the guanidinium isothiocyanate/acid phenol procedure (29). 
Purified RNA  was  resuspended at  the RNA equivalent of 106 
cells/2 #1. The reverse transcription was performed in 1  x  PCR 
buffer with 2/~1 RNA solution as described elsewhere (30). Viral 
cDNA was obtained as described  before (9). 
Oligonucleotides to amplify all Mtv ORFs were chosen on the 
basis of high degree of conservation between the sequenced ORF 
molecules,  resulting in a 898-bp PCR product:  5' oligo, TCG- 
TGCTCGCAGGGCTCTCAC (VJ84);  3' oligo, GTGTCGACC- 
CAAACCAAGTCAGGAAACCACTTG (VJ71). To specifically  de- 
tect MMTV(SW),  a 3'  oligonucleotide specific for the unique 
MMTV(SW)/Mtv-70RF  COOH terminus was used in combi- 
nation  with  VJ84,  yielding a  766-bp  PCR  product.  3'  oligo, 
GCGACCCCCATGAGTATATTTC  (VJ83). A primer in the 5' non- 
coding region at the 5' splicing site for subgenomic mRNAs (31) 
was designed to specifically amplify spliced OILF mRNA: 5' oligo, 
CAGGGAACTGCAGTCTCGCCTA. The 3' oligo VJ83 described 
above was used to ascertain specificity for the MMTV(SW) ORF. 
As a control for the cDNA preparation we used primers specific 
for B-actin:  5' oligo, GAGGGAAATCGTGCGTGACATCAA; Y 
oligo, GGAACC GCTCGTTGCCAATAGTGA. 
DNA or cDNA was boiled for 3 rain in the presence  of the 
360  Mouse  Mammary Tumor Virus Infection of B Cells oligos. The conditions for PCR  were  1 min at 55~  1 rain at 
72~  1 min at 93~  for 40 cycles, and 7 min at 72~  in lx  PCR 
buffer containing 20 mM Tris-HC1, pH 8.4, 50 mM KC1, 0.2 mM 
dNTP,  2 mM MgC12 (1.5 mM for the ORF mRNA  and ~-actin 
primers), 0.01% gelatin, 2.5 U  Taq polymerase (AmpliTaq; Perkin 
Elmer Corp., Pomona, CA) using a DNA thermal cycler (Perkin 
Elmer  Corp.).  20%  of the  PCR  reaction was  size ffactionated 
in 1.5%  agarose, stained with ethidium bromide, and visualized 
under  UV. 
Results 
Acute Infection of BALB/c Mice with MMTV(SW) Induces 
a B Cell Response.  After footpad injection of adult BALB/c 
mice with  109 MMTV(SW) particles purified from mouse 
milk,  we observed an approximately fourfold size increase 
of the local (popliteal, paraaortic, and inguinal) lymph nodes. 
As noted previously (9) this size increase was partially due 
to an increase of Mls-l~-reactive VB6 + CD4 + T  ceUs from 
10.9  •  0.5% of CD4 in animals injected with an MMTV- 
free  milk  preparation  to  24.4  •  2.6%  at  day  6  after 
MMTV(SW)  infection.  In contrast  non-Mls-P-reactive  T 
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Local immune response to MMTV(SW). 109 MMTV(SW) 
particles were injected into one hind footpad of recipient BALB/c mice. 
At appropriate time points after injection the local lymph nodes (popliteal, 
paraaortic, and inguinal) were isolated, pooled, and analyzed for lympho- 
cyte subsets using flow microfluorometry. (24) Absolute cen counts in local 
lymph nodes for VB6 + CD4 + T cells (A) and VB14 + CD4 + T cells ([-1) 
after MMTV(SW) infection and for V~6 + CD4 + T  cells (A) in mice 
injected with a MMTV-ffee milk preparation. Data represent mean values 
from two  to  four  animals  per  time point.  (B) B  cell response  upon 
MMTV(SW) injection (O) and upon injection of the control milk prepa- 
ration (O). Data represent mean values derived from the same animals 
as above. 
playing 9.9  _+  1.2% ofCD4 + T cells in control animals  and 
8.6  •  1.5%  at day 6 after infection.  Absolute cell counts 
for the different CD4 + T  cell subsets over time are shown 
in Fig.  1 A. The T  cell response in the local lymph nodes 
was paralleled by a specific increase of B cells from 20.0  _+ 
2.3% of total lymph node cells in noninfected animals to 32.7 
_  3.0%  at day 6 after infection (Fig.  1 B). Both B and T 
cell responses were virus dependent since the MMTV-free milk 
preparation did not induce a detectable response (Fig.  1, A 
and B). 
Using a combination of cell surface labeling and DNA con- 
tent analysis, we determined the percentage of cells in cycle. 
Between days 4 and 6 after MMTV(SW) infection a minor 
fraction of B cells (2%) was found in S+ G2 +M phase com- 
pared with 0.8% in noninfected control lymph nodes. Slightly 
more (4%) CD4 + T  cells  are in cycle at day 4  (compared 
with  0.6%  in  controls).  Analysis of MMTV(SW)  ORF- 
responsive T  cells indicated an enrichment  of cycling cells 
(8%  among V/~6 + T  cells). 
Titration  of the injected MMTV(SW) dose from 10  9 to 
10  6 virus particles indicates that the B cell response is high 
as long as there is a significant CD4 + VB6 + T cell response 
(Fig. 2). This suggests that  a critical virus dose is required 
to induce a detectable local immune  response. 
The B  Cell Response to MMTV(SW) Depends on the Pres- 
ence of Mls-1~  T  Cells.  BALB.D2 mice are (Mtv-7 +) 
Mls-la-congenic BALB/c mice. Therefore, they delete >95% 
of the T  cells  that  react with Mls-1 a within  the first  10 d 
after birth (32).  After injection of exogenous MMTV(SW) 
into BALB.D2 mice the B cell response was profoundly di- 
minished compared with the response in control BALB/c mice. 
Both BALB/c and BALB.D2 mice, however, responded equally 
well to MMTV(C3H),  an exogenous MMTV that encodes 
an ORF molecule interacting with T cells expressing the V/314 
and V~315 TCRs  (2)  (Table  1). 
CD4 §  V~6 §  T  Cells Are Su~cient to Stimulate a B  Cell 
Response to MMTV(SW).  Nude mice lack a thymus and are 
therefore not able to generate a functional T  cell compart- 
ment; however, they can be efficiently reconstituted with T 
calls (26). We reconstituted BALB/c nu/nu mice with either 
10  s CD4 + V/36 + or CD4 + VB14 § T  cells isolated by cell 
sorting from lymph nodes of normal BALB/c mice. Greater 
than 90% of the CD4 + T calls in transferred nude mice ex- 
pressed the selected phenotype, whereas contamination with 
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Figure 2.  Effect of MMTV(SW) 
dose on T  and B cell responses. 
Response of VB6 + T cells indi- 
cated as percentage of CD4 § T 
cells (O) and concomitant B cell 
response  (0) (indicated as abso- 
lute cell counts in popliteal, para- 
aortic, and inguinal lymph nodes) 
upon titration of the MMTV(SW) 
dose. Data represent mean values 
of two animals at day 4 after in- 
jection of MMTV(SW). 
361  Held et al. Table  1.  B  Cell Response  to MMTV  in  Mls-I ~ Congenic  Mice 
BALB/c  BALB.D2 
Virus  injection  n  B cells*  n  B cells 
None  9  0.7  _+  0.5  7  1.1  +  0.7 
MMTV free  3  0.7  _+ 0.3  2  0.9/0.6 
MMTV (C3H)  3  3.4  _+  1.3  3  3.5  _+  1.2 
MMTV (SW)  4  6.9  _+  1.4  4  2.2  _+  1.1 
* Absolute numbers  ( x  106) ( _+ SD) of B cells in popliteal, paraaortic, 
and inguinal lymph nodes 6 d after injection of 109 MMTV particles or 
an  MMTV-free milk preparation. 
with either V~14 + or V36 + CD4 + T cells had 8.6  _+  3.9% 
CD4 § T  cells or 9.0  _+  4.0%  CD4 + T  cells  among  total 
lymph node cells, respectively. In comparison, normal BALB/c 
mice have "%0% CD4 + T cells in peripheral lymph nodes, 
10%  of which are either  V36 + or V~/14 +. 
After injection of MMTV(SW) or MMTV(C3H) into these 
reconstituted nude mices we assessed the immune responses 
in the local lymph nodes and compared these with control 
BALB/c nu/nu mice (displaying 0.6  _+  0.5% CD4 + T  cells 
among total lymph node cells).  An efficient B cell response 
is induced whenever the appropriate combination of OKF- 
specific  CD4 + T  cell and MMTV  is present,  e.g.,  CD4 + 
V/36 + T cells and infection with MMTV(SW) (Table 2). As 
seen before for BALB.D2 mice a small B cell response is seen 
in nonreconstituted  nude mice, possibly reflecting a minor 
T ceU-independent B cell response. Alternatively,  residual reac- 
tive T  cells in BALB.D2 mice and/or ORF-reactive T  cells 
arising  spontaneously in nude mice may contribute to this 
response. 
MMTV(S W) Infection  Induces Ig Secretion by B Cells.  When 
5  x  10  s lymphocytes were cultured  for 3  d  after in  vivo 
MMTV(SW) infection, we observed production of Ig (IgM 
+  IgG) in supernatants  of lymphocytes from infected but 
not from uninfected animals.  Preliminary experiments indi- 
cated that maximal secretion of Ig by B cells from local lymph 
nodes  occurred  6  d  after  injection  of MMTV(SW)  (not 
shown). 
Ig secretion by lymph node cells from BALB/c mice in- 
creased from 0.1 ]~g/ml (uninfected animals,  21.5% B cells 
present in culture) to 15 #g/ml by lymphocytes from infected 
animals  (35.4%  B cells).  However, the absence of Mls-1 ~- 
reactive T  cells in BALB.D2 mice decreased the Ig produc- 
tion '~10-fold (1.5 #g/ml)  (Fig.  3 A).  Upon MMTV(SW) 
infection of reconstituted BALB/c nu/nu mice, the presence 
of only CD4 + VB6 + T cells restored high Ig production (20 
/xg/ml) (85.1% B cells in culture) compared with nonrecon- 
stituted  BALB/c  nu/nu  (0.5  #g/ml)  (91.2%  B  cells)  or 
V~14 + CD4 + reconstituted nude mice (2 #g/ml)  (84.0% 
B cells)  (Fig.  3 B). 
The Ig subclass distribution  in the supernatants  derived 
from infected BALB/c lymph node cells revealed a predomi- 
nant IgG response.  Among the IgG subclasses the IgG2a iso- 
type was found at a 10-fold higher amount  than  the other 
IgG subclasses.  This response was greatly diminished when 
OKF-reactive CD4 + T  cells  were absent  as in the case of 
t~LB.D2,  BALB/c nu/nu,  and V~14 + CD4 + reconstituted 
nude mice (Fig.  4). 
In Vivo MMTV(SW) Infects B Cells Predominantly.  Anal- 
ysis of lymph node cells  for MMTV(SW)  ORF DNA by 
the PCR indicated that reverse-transcribed viral genome was 
detectable in draining lymph nodes 4 d after virus injection 
(Fig.  5 A). Thus,  the presence of a reverse-transcribed viral 
genome  coincided  with  a CD4 §  V~6 +  T  and B  cell  re- 
sponse as shown in (Fig.  1). Since nondraining lymph nodes 
were still MMTV(SW) negative 3 wk after local infection, 
virus spread might be very inefficient. Control PCR. specific 
for all Mtv's present, i.e., exogenous and endogenous Mtv's 
(Mtv 6, 8, and 9 in BALB/c mice), indicated that they could 
be amplified with equal efficiency from all the different samples 
(Fig.  5 A). 
To determine the phenotype of MMTV(SW)-infected cells 
we performed PCR. analysis on FACS|  B and T cells 
from lymph node cells 6 d after infection. As shown in Fig. 
5 B, B cells are the primary target of MMTV(SW) infection. 
Only a very weak signal was detected in the T cell prepara- 
Table  2.  Immune Response  Induced  by MMTV  in Either  V~6 + CD4 + or  V~14 + CD4 + T  Cell-reconstituted  BALB/c  nu/nu  Mice 
BALB/c nu/nu reconstituted  with: 
No cells  VB14 + CD4*  T  cells  VB6 + CD4 + T cells 
Injection  B  cells*  CD4 +*  B  cells  Vf114 +  CD4 +  B cells  VB6 +  CD4 + 
None  2.3  _+  1.4  0.03  -+  0.02  2.9  _+  0.8  0.3  -+  0.1  2.1  _+  0.4  0.3  _+  0.1 
MMTV(C3H)  2.6  _+  1.3  0.02  _+ 0.02  9.9  +  3.9  0.6  +  0.2  3.9  _+  1.8  0.3  _+ 0.1 
MMTV(SW)  3.4  _+ 0.5  0.02  _+ 0.02  4.0  +_ 0.7  0.2  +  0.1  10.5  _+ 2.2  0.8  _+ 0.2 
" Absolute cell counts  ( x  106) ( + SD) in popliteal, paraaortic,  and inguinal lymph nodes from three to five mice determined between days 4 and 
six after injection of 109 MMTV  particles.  Statistically significant increases  are underlined. 
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Figure 3.  Ig  secretion  by MMTV(SW)-infected  lymph node cells. 
Lymph node cells were isolated 6 d after infection with MMTV(SW), 
and 5  x  10  s cells were cultured for 3 d in 200/zl of complete DMEM 
supplemented with 5% FCS without any further stimulation. Total Ig 
(IgG +  IgM) levels  in supernatants were subsequently determined using 
isotype-specific sandwich ELISAs as described in Materials and Methods. 
Supernatants were derived from:  (.4) infected and noninfected BALB/c 
or BALB.D2 mice; and (B) infected and noninfected BALB/c nu/nu (nu/nu) 
controls or BALB/c nu/nu mice reconstituted  with either VB14  + CD4 + 
T  cells (VB14/nu) or VB6 + CD4 + T  cells (VB6/nu). 
tion, which could be due to crosscontamination, although 
the FACS|  cell preparations were >99%  pure B or 
T  cells upon reanalysis. Again endogenous Mtv ORFs are 
amplified equally well from the different DNA samples (Fig. 
5 B). 
Analysis of  MMTV(SW) ORF mRNA Expression.  To ad- 
dress the issue whether ORF mRNA is present during the 
MMTV(SW)-induced local immune  response in vivo, we used 
a PCR primer within the 5' noncoding  region at the 5' splicing 
BALB/c 
BALB.D2  ~a  []  IgM 
i  []  lgGl 
nu/nu  []  IgG2a 
m  ￿9  IgG2b 
V~14/nu  ~  ￿9  IgG3 
V~6/nu  ~  , 
0  5  10  15 
Ig  (~Lg/ml) 
Figure 4,  Isotype pattern of Ig production by MMTV(SW)-infected 
lymph node cells. Lymph node cells from MMTV(SW)-infected  BALB/c, 
BALB.D2,  BALB/c nu/nu (nu/nu), and V~14 +  CD4 +  (Vt~14/nu) or 
V/~6  + CD4*  Oll~6/nu) reconstituted  nude mice were isolated and cul- 
tured as described above. Ig subclass distribution was determined using 
isotype-specific sandwich ELISAs as described in Materials and Methods. 
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Figure 5.  Analysis  ofMMTV(SW) infection by PC1L (,4) Lymphnode 
cells  from draining (popliteal  and paraaortic) or nondraining (axillary)  lymph 
nodes (LN) were isolated at the indicated time points after injection of 
MMTV(SW) into the footpad of BALB/c mice. Lymphocyte DNA was 
isolated and subjected to PCR analysis specific  for MMTV(SW) (and Mtv- 
7) OKF DNA yielding a 766-bp PCK product. As a control we amplified 
all Mtv OKFs present in BALB/c mice, including endogenous Ma,'s 6, 
8, and 9, yielding a 898-bp PCK product.  (/3) At day 6 after infection 
lymph node cells were separated into B and T cells (both populations were 
>99% pure) using FACS  |  Isolated DNA was then subjected to PCR 
specific  for MMTV(SW) ORF DNA or all Mtv ORFs as described above. 
site for subgenomic mRNA's (31) in combination with the 
MMTV(SW)  (and Mtv-7)  ORF-specific primer described 
above. This combination should allow a PCR amplification 
from spliced MMTV(SW) ORF mRNAs, but not from the 
unspliced MMTV(SW) genome or the integrated MMTV- 
(SW) DNA or the endogenous Mtv-7, since the two target 
sequences are separated by "~8 kb containing the gag-pol-env 
genes. As shown in Fig. 6 A, the O1LF mRNA-specific primers 
indeed do not yield a detectable PCR product from BALB/c 
and BALB.D2 DNA or from the unspliced (genomic) MMTV- 
(SW) cDNA. The latter result demonstrates that the mature 
virion does not contain spliced OILF mRNA species. The 
control PCR amplification using primers located within the 
ORF molecule, however, gives the expected band at 0.7 kb 
from the Mtv-7 + BALB.D2  DNA and from the unspliced 
MMTV(SW) cDNA (Fig. 6 A). To demonstrate MMTV(SW) 
ORF expression  we analyzed  cellular  RNA isolated from 
lymph node cells after MMTV(SW) infection for the pres- 
ence of spliced O•F  mRNAs.  As shown in Fig.  6 B, no 
MMTV(SW) ORF mRNA was amplified from noninfected 
BALB/c mice, whereas a signal was readily detected from RNA 
obtained from lymph node cells 6 d after infection. Upon 
separation by FACS  |  into T  and B cells (both populations 
were >99.5%  pure) ORF mRNA was almost exclusively 
amplified from the RNA obtained from the B cell popula- Figure  6.  Analysis  ofMMTV(SW)  ORF mRNA  expression  by PCR. 
(A) Specificity  of the PCR for spliced ORF mRNA. A primer at the 
5' splicing  site for subgenomic  mRNAs together  with the MMTV(SW) 
(and Mtv-7) ORF-specific  primer  described  in Fig. 5 were  tested  on genomic 
DNA from  BALB/c and BALB.D2  mice  and on the cDNA derived  from 
the MMTV(SW) genome  in which the splice site and the ORF are sepa- 
rated by '~8 kb of gag-pol-env sequences. The quality  of these prepara- 
tions was confirmed  by primers that amplify  a 766-bp stretch  within the 
MMTV(SW) or Mt~7 OR.F, which  do not require a splicing  event. The 
quality of the BALB/c  DNA was confirmed  with primers that amplify 
all endogenous  Mtv's (see  Fig. 5 B). (B) Lymph  node cells from  draining 
(popliteal and paraaortic) lymph  nodes  were  isolated  at day 6 after  injec- 
tion of MMTV(SW) into the footpad  of  BALB/c mice. Lymph  node  cells 
were then  separated  into B and T cells  using  FACS  |  to a purity  of  >99.5%. 
Lymph  nodes  from  noninfeeted  BALB/c  mice  were  used  as a control.  After 
RNA isolation,  the prepared  cDNA was subjected  to PCR analysis  specific 
for spliced  MMTV(SW)  ORF mRNA. The observed  PCR products  were 
1.0 and 1.8 kb. The quality  of the cDNAs was confirmed  by control  PCR 
specific for B-actin mRNA. 
tion. ORF mRNA was detected as early as day 4 (not shown). 
PCR amplification with primers specific for/5-actin mRNA 
demonstrated that all RNA preparations were of comparable 
quality. 
Since the oligos used for amplification of ORF transcripts 
do not amplify the entire 3' nor most of the 5' untranslated 
region, the PCR product is '~0.65 kb shorter than the cor- 
responding transcript. Thus, the 1.0-kb PCR product fitted 
the prediction for a putative ORF transcript that has been 
described  as an mRNA of '~1.7 kb (33).  Surprisingly, we 
observed  a second PCR product of 1.8 kb (Fig.  6 B)  that 
would correspond to an mRNA of '~2.5 kb. The specificity 
of both transcripts for MMTV(SW) is indicated by the fact 
that no such amplification products were obtained from unin- 
fected BALB/c RNA and from DNA samples (Fig. 6, A and 
B). Preliminary sequence  analysis indicates  that the 1.0-kb 
PCR product corresponds to the putative ORF transcript 
(33). The longer transcript might be related to a 1.85-kb tran- 
script found in Eb4 thymoma cells, taking into account a 
491-bp  deletion found in the 3' LTR of the EL4 proviral 
genome (34). 
Discussion 
Infection with MMTV occurs vertically after transmission 
from mother to offspring by the milk. Several lines of evi- 
dence suggest that the immune system and particularly T 
cells play a crucial role for MMTV infection and transport 
to the mammary gland. However, early MMTV infection 
events, including the role of the superantigen activity in viral 
infection and that of the different lymphocyte subsets as puta- 
tive intermediate virus hosts,  are  still poorly understood. 
We show here that B cells are the primary target for MMTV 
infection since  ORF  transcripts  and  the bulk  of reverse- 
transcribed viral genome are present in B cells. Since we show 
that the mature virus particle does not contain ORF tran- 
scripts  and it is believed that ORF protein is not present in 
the mature virion (35), it is likely that after infection, de novo 
ORF protein expression  and presentation in the context of 
MHC class II antigens (36) by infected B cells leads to stimu- 
lation  of ORF-reactive  CD4 +  T  cells.  B  cells  are  then 
stimulated by these activated CD4 + T  cells. This sequence 
of events is supported by the fact that cycling T cells are ob- 
served before cycling B cells in the local response.  The hy- 
pothesis that MMTV(SW)-infected B cells present the ORF 
molecule to T cells, thereby inducing direct B-T cell interac- 
tion, is consistent with several lines of evidence.  (a) CD4 § 
T cells respond in vitro to ORF molecules from endogenous 
Mtv's presented by B cells in the context of MHC class II 
molecules.  The interaction can be blocked by antibodies to 
MHC class II, CD4, or the TCR (for review see reference 
37).  (b) B cells are polyclonally inducible using Mls as the 
target antigen (13). Direct Th-B cell interaction was required 
for the initial B cell activation step, whereas activation of by- 
stander B cells not expressing the Mls determinant has been 
shown by some (14) but not by others (13). 
After  MMTV  infection  the  presence  of ORF-reactive 
CD4 § T  cells was both necessary  and sufficient  to induce 
a response  among B cells. This B cell stimulation may lead 
to an increased  probability of reinfection and/or may indi- 
cate that a rare  subset  of infected B cells is amplified. This 
latter point is consistent with the data showing a low per- 
centage of proliferating B cells. In any case an activated B 
cell should provide an appropriate milieu to transcribe the 
MMTV  genome, as has been demonstrated for germline- 
transmitted, endogenous Mtv's (38). 
After accumulation in the local lymph nodes some B cells 
undergo differentiation and secrete antibodies. The Ig sub- 
class distribution in culture supernatants of  lymphocytes from 
infected animals implies a T  cell- and ORF-dependent Ig 
production. This is supported by the finding that infected 
BALB/c nu/nu mice do not produce significant amounts of 
IgG and that efficient IgG production in nude mice can be 
reconstituted by MMTV ORF-reactive Th cells. A predom- 
inant IgG2a secretion by infected BALB/c lymph node cells 
suggests that IFN-3,-producing Th type I cells (39) are in- 
duced upon MMTV infection. In fact IFN-3, production has 
been demonstrated in Mls-specific Th cell clones (40, 41) and 
in secondary in vitro Mls responses (H. R. MacDonald, un- 
published results).  In this respect it is interesting to note that 
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natal injection of Mls-l'-bearing B cells could be reversed by 
anti-IFN-3' antibodies (17). 
The IgG2a subclass of antibodies has generally been found 
as specific (antiviral) as well as nonspecific (polyclonal) anti- 
bodies  elicited  in  mice  by  viral  infections  (42).  After 
MMTV(SW) infection anti-MMTV antibodies were found 
at low but comparable titers in supernatants of  both infected 
BALB/c and BALB.D2 mice (not shown), indicating that 
the viral superantigen probably does not play a role in the 
MMTV-specific antibody response.  However,  the massive 
IgG2a response  of BALB/c or V/~6  + CD4 + reconstituted 
nude  mice  is  dependent  on  the  viral  superantigen  since 
BALB.D2, nude, or V314 + CD4 + reconstituted nude mice 
secrete only low amounts of IgG2a antibodies. Thus, poly- 
clonal IgG2a production depends on the presence  of both 
the superantigen and CD4 + T  cells reactive  with it. 
Recently Golovkina et al.  (12) showed that deletion of 
superantigen-reactive T  cells induced by transgenic expres- 
sion of a superantigen led to reduced transport of the corre- 
sponding exogenous MMTV to the mammary gland. These 
data have been interpreted by others to mean that superantigen- 
reactive T ceils are the primary target for MMTV infection 
(43).  However, our experiments show that B cells are the 
primary target of infection and that the absence of superan- 
tigen-reactive T cells does not allow efficient stimulation of 
presumably infected B cells. Similarly, earlier data published 
by Tsubura et al.  (11) indicate that T  cells but not B cells 
from infected mice can transfer MMTV infection to nude 
mice. Again our experiments suggest that the absence of T 
cells in nude mice does not allow efficient stimulation of in- 
fected B cells. Thus, infected B cells alone may not be able 
to transfer MMTV to the mammary gland in nude mice. 
With regard to the latter study it should be noted that we 
assayed for T cell infection very early (6 d) after local infec- 
tion. However, Tsubura et al. (11) reported MMTV trans- 
port to the mammary gland of nude mice after transfer of 
T  cells isolated 6-7 mo after infection. Infection of T  cells 
may therefore be a late event in MMTV transmission. 
Continuous deletion of ORF-reactive CD4 + T cells in in- 
fected mice (9) may reflect an ongoing T cell stimulation due 
to persistence of MMTV(SW)-infected B cells. Thus, MMTV 
ORF-induced, T  cell-dependent B cell stimulation would 
assure the maintenance and possibly the amplification of the 
virus and increase the probability of infecting the mammary 
gland. The absence of superantigen-reactive T cells may de- 
prive the intermediate virus host and thus the virus from this 
amplification step and therefore lead to an inefficient infection. 
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